The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication
- PMID: 18725912
- PMCID: PMC2797569
- DOI: 10.1038/mp.2008.94
The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication
Abstract
Despite significant advances in the study of obsessive-compulsive disorder (OCD), important questions remain about the disorder's public health significance, appropriate diagnostic classification, and clinical heterogeneity. These issues were explored using data from the National Comorbidity Survey Replication, a nationally representative survey of US adults. A subsample of 2073 respondents was assessed for lifetime Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV) OCD. More than one quarter of respondents reported experiencing obsessions or compulsions at some time in their lives. While conditional probability of OCD was strongly associated with the number of obsessions and compulsions reported, only small proportions of respondents met full DSM-IV criteria for lifetime (2.3%) or 12-month (1.2%) OCD. OCD is associated with substantial comorbidity, not only with anxiety and mood disorders but also with impulse-control and substance use disorders. Severity of OCD, assessed by an adapted version of the Yale-Brown Obsessive Compulsive Scale, is associated with poor insight, high comorbidity, high role impairment, and high probability of seeking treatment. The high prevalence of subthreshold OCD symptoms may help explain past inconsistencies in prevalence estimates across surveys and suggests that the public health burden of OCD may be greater than its low prevalence implies. Evidence of a preponderance of early onset cases in men, high comorbidity with a wide range of disorders, and reliable associations between disorder severity and key outcomes may have implications for how OCD is classified in DSM-V.
Figures
Similar articles
-
Obsessive--compulsive disorder: prevalence, correlates, help-seeking and quality of life in a multiracial Asian population.Soc Psychiatry Psychiatr Epidemiol. 2012 Dec;47(12):2035-43. doi: 10.1007/s00127-012-0507-8. Epub 2012 Apr 17. Soc Psychiatry Psychiatr Epidemiol. 2012. PMID: 22526825
-
Subthreshold symptoms and obsessive-compulsive disorder: evaluating the diagnostic threshold.Psychol Med. 2010 Jun;40(6):989-97. doi: 10.1017/S0033291709991012. Epub 2009 Sep 7. Psychol Med. 2010. PMID: 19732479
-
Obsessive-compulsive disorder in postmenopausal women: prevalence, clinical features, and comorbidity.Aust N Z J Psychiatry. 2010 Feb;44(2):183-7. doi: 10.3109/00048670903393639. Aust N Z J Psychiatry. 2010. PMID: 20113307
-
[Current and emerging features of obsessive-compulsive disorder--trends for the revision of DSM-5].Seishin Shinkeigaku Zasshi. 2012;114(9):1023-30. Seishin Shinkeigaku Zasshi. 2012. PMID: 23198591 Review. Japanese.
-
Should OCD be classified as an anxiety disorder in DSM-V?Depress Anxiety. 2010 Jun;27(6):495-506. doi: 10.1002/da.20699. Depress Anxiety. 2010. PMID: 20533366 Review.
Cited by
-
Assessment of the Prevalence and Types of Mental Compulsions in Patients With Obsessive-Compulsive Disorder in North Karnataka: A Cross-Sectional Study.Cureus. 2024 Oct 20;16(10):e71960. doi: 10.7759/cureus.71960. eCollection 2024 Oct. Cureus. 2024. PMID: 39569263 Free PMC article.
-
The Longitudinal Relationship Between Brain Morphology and Obsessive-Compulsive Symptoms in Children From the General Population.JAACAP Open. 2023 Dec 25;2(2):126-134. doi: 10.1016/j.jaacop.2023.11.003. eCollection 2024 Jun. JAACAP Open. 2023. PMID: 39554206 Free PMC article.
-
Transdiagnostic Anxiety-Related Increases in Information Sampling are Associated With Altered Valuation.Comput Psychiatr. 2024 Nov 6;8(1):202-216. doi: 10.5334/cpsy.100. eCollection 2024. Comput Psychiatr. 2024. PMID: 39524300 Free PMC article.
-
Augmentation of cognitive-behavioural therapy for obsessive-compulsive and anxiety disorders: a protocol for a systematic review and meta-analysis.BMJ Open. 2024 Nov 1;14(10):e090431. doi: 10.1136/bmjopen-2024-090431. BMJ Open. 2024. PMID: 39486819 Free PMC article.
-
The effect of major depressive disorder comorbidity on ischemia-modified albumin levels, a marker of oxidative stress, and antioxidant defense system in patients with obsessive compulsive disorder.Front Psychiatry. 2024 Oct 15;15:1469640. doi: 10.3389/fpsyt.2024.1469640. eCollection 2024. Front Psychiatry. 2024. PMID: 39473913 Free PMC article.
References
-
- American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III) American Psychiatric Association; Washington, DC: 1980.
-
- Rasmussen SA, Tsuang MT. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry. 1986;143:317–322. - PubMed
-
- Fernandez Cordoba E, Lopez-Ibor Alino J. [Use of monochlorimipramine in psychiatric patients who are resistant to other therapy]. Actas Luso Esp Neurol Psiquiatr. 1967;26:119–147. - PubMed
-
- Marks IM, Hodgson R, Rachman S. Treatment of chronic obsessive-compulsive neurosis by in-vivo exposure. A two-year follow-up and issues in treatment. Br J Psychiatry. 1975;127:349–364. - PubMed
-
- Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry. 1989;46:1012–1016. - PubMed
Publication types
MeSH terms
Grants and funding
- K01-MH076162/MH/NIMH NIH HHS/United States
- R01 DA016558/DA/NIDA NIH HHS/United States
- U01-MH60220/MH/NIMH NIH HHS/United States
- K01 MH076162/MH/NIMH NIH HHS/United States
- R01-MH069864/MH/NIMH NIH HHS/United States
- U13 MH066849-06/MH/NIMH NIH HHS/United States
- U01 MH060220/MH/NIMH NIH HHS/United States
- R13-MH066849/MH/NIMH NIH HHS/United States
- U13 MH066849/MH/NIMH NIH HHS/United States
- R01 MH070884-04/MH/NIMH NIH HHS/United States
- R13 MH066849/MH/NIMH NIH HHS/United States
- R03 TW006481-03/TW/FIC NIH HHS/United States
- R03 TW006481/TW/FIC NIH HHS/United States
- R01 MH069864/MH/NIMH NIH HHS/United States
- R01 MH069864-04/MH/NIMH NIH HHS/United States
- K01 MH076162-03/MH/NIMH NIH HHS/United States
- R01 DA016558-06/DA/NIDA NIH HHS/United States
- K05 DA015799/DA/NIDA NIH HHS/United States
- R03-TW006481/TW/FIC NIH HHS/United States
- R01 MH070884/MH/NIMH NIH HHS/United States
- U01 MH060220-08/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous